Close Menu

pain

Researchers developing the gene expression-based test say it could bring objectivity to a subjective diagnosis and result in more targeted treatments.

The designation will help the company accelerate the process of bringing the opioid addiction risk test through regulatory review and clearance.

Smaller labs, hospital outreach labs, and labs servicing high numbers of elderly are thought to face the highest risks.